The number of COVID-19 vaccination doses administered per 100 people in Jordan rose to 89 as of Oct 27 2023. This dataset includes a chart with historical data for Jordan Coronavirus Vaccination Rate.

Jordan: Percent of children ages 12-23 months with DPT immunization: The latest value from 2022 is 77 percent, unchanged from 77 percent in 2021. In comparison, the world average is 85 percent, based on data from 187 countries. Historically, the average for Jordan from 1980 to 2022 is 91 percent. The minimum value, 30 percent, was reached in 1980 while the maximum of 99 percent was recorded in 1997.

Jordan JO: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 98.000 % in 2016. This records a decrease from the previous number of 99.000 % for 2015. Jordan JO: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 95.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 99.000 % in 2015 and a record low of 30.000 % in 1980. Jordan JO: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Jordan – Table JO.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Jordan JO: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 96.000 % in 2016. This records an increase from the previous number of 94.000 % for 2015. Jordan JO: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 94.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 99.000 % in 2006 and a record low of 29.000 % in 1980. Jordan JO: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Jordan – Table JO.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

BackgroundSeasonal Influenza is a major cause of morbidity and mortality worldwide. Despite the well-established preventive role of the influenza vaccine particularly for patients at high risk, influenza vaccine uptake remains suboptimal. In Jordan, data on the influenza vaccine uptake among adults with chronic diseases at high risk of influenza complications is still lacking.MethodsA cross-sectional study was conducted to assess influenza vaccine knowledge, attitudes, uptake, and barriers among adults with selected chronic disease in Jordan. Data was collected via a structured questionnaire based on the health belief model (HBM). The face-to-face interviews were conducted between February and June 2023 at multiple healthcare centers and hospitals are representative sites of Jordan.ResultsA total of 786 participants completed the study questionnaire with a mean age of 50.04 ± 15.9 years. There was a low uptake rate of influenza vaccine (10.4%) during the 2022/2023 season, while around one third of participants (32.7%) reported history of been ever vaccinated against influenza. This study identified different predictors of influenza vaccine uptake such as advice from the healthcare professional, history of complications from influenza, availability of free influenza vaccine and awareness about the vaccine availability. Worry about the vaccine safety was one of the important detected barriers.ConclusionSimilar to the global trend, particularly in developing countries, the influenza vaccine uptake rate is low among adults with different high-risk illnesses in Jordan. Results of the study provided baseline data for future interventions to improve the uptake rates of influenza vaccines in Jordan.

Jordan JO: Immunization: HepB3: % of One-Year-Old Children data was reported at 98.000 % in 2016. This records a decrease from the previous number of 99.000 % for 2015. Jordan JO: Immunization: HepB3: % of One-Year-Old Children data is updated yearly, averaging 97.000 % from Dec 1995 (Median) to 2016, with 22 observations. The data reached an all-time high of 99.000 % in 2015 and a record low of 54.000 % in 1995. Jordan JO: Immunization: HepB3: % of One-Year-Old Children data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Jordan – Table JO.World Bank: Health Statistics. Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

BackgroundThere is a need to establish the effectiveness of the coronavirus disease 2019 (COVID-19) vaccines in reducing COVID-19-related hopitalization of patients in Jordan. As the vaccination program accelerates, it is important to determine whether the vaccines' effectiveness (VE) has successfully reduced the number of acute cases admitted to hospital.MethodsTo determine the efficacy of Pfizer-BioNTech and Sinopharm COVID-19 vaccines among Jordanian patients admitted to Prince Hamza hospital, a single center case-control study was performed. The study analyzed the hospitalization rates of vaccinated (n = 536) and unvaccinated (n = 585) individuals across the 2-month period from February 6 to April 6, 2022. The cases were patients who tested positive for SARS-CoV-2 (“case-patients”), whilst the control group were hospital patients who did not test positive for SARS-CoV-2 (“control-patients”).ResultsThis study found that among 1,121 total participants (561 cases and 560 control), the overall vaccine effectiveness (VE) among the participants was 84% (95% Cl 79–88%). VE was higher in females (88%, 95% Cl 84–93%) than in males (77%, 95% Cl 67–84%) (p < 0.001), and it was highest in those between the ages of 18 and 28-years-old (95%, 95% CI 86–98%). For patients with pre-existing conditions, including chronic heart disease, chronic lung disease, and diabetes, VE was higher compared to patients with no comorbidities, though the difference was not statistically significant. Finally, in comparing all vaccinated participants, VE was higher for those who received the Pfizer vaccine (VE = 92%, 95% CI 88–94%) (OR 0.08, 95% CI 0.06–0.12) than for those who received the Sinopharm vaccine (VE = 67%, 95% CI 52–78%) (OR 0.33, 95% CI 0.22–0.48); (p = 0.011).ConclusionOverall, Pfizer and Sinopharm vaccines were found to be effective in limiting hospitalizations for acute cases of coronavirus among Jordanian adult's patient's cohort between February 6 and April 6, 2022, especially among patients with comorbidities.

Statistics illustrates monthly imports of vaccines for human medicine in Jordan from January 2019 to June 2025.

89.0 (%) in 2019. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.

In 2024, the Jordanian vaccine market increased by 7.2% to $33M, rising for the third year in a row after three years of decline. The market value increased at an average annual rate of +2.5% over the period from 2012 to 2024; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, the market attained the peak level at $38M in 2018; however, from 2019 to 2024, consumption remained at a lower figure.

95.0 (%) in 2023. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.

COVID-19 case severity by demographic characteristics, comorbidities, pregnancy, and vaccination status in Azraq camp, Jordan.

Abstract

The proliferation of mis- and disinformation threatens to erode the credibility of public institutions and limit their capacity to implement policies that enhance public well-being. While misinformation represents an urgent global challenge, relatively little research has examined solutions in low- and middle-income countries. We experimentally test the impact of a novel WhatsApp chatbot game prebunking inoculation intervention in Jordan to boost capacity to identify common misinformation techniques and reduce the likelihood of sharing misleading headlines with others?effectively ‘inoculating’ them against misinformation. A sample of 2,851 participants was recruited online and randomly assigned to five study arms: (1) comprehensive game-based inoculation, (2) brief game-based inoculation that highlighted examples of only misinformation, (3) infographics-based inoculation, (4) exposure to placebo infographics unrelated to misinformation, and (5) pure control. To evaluate the impact of our intervention, we assess two main outcomes: (i) ability to accurately discern headlines using misinformation techniques and headlines that do not use misinformation techniques, and (ii) discernment in sharing the two types of headlines.

Kind of data

Sample survey data [ssd]

Sampling procedure

We conducted this study between October 27, 2022 and November 23, 2022. Participants were recruited through Facebook advertisements targeting users aged 18 years or older and located in Jordan with WhatsApp installed. The advertisements marketed our chatbot-based game under the title “Find the Fake”, inviting people to play a challenge related to the spread of misinformation online for a chance to win 70 Jordanian Dinar (roughly equivalent to US$ 100).

After participants clicked the ads, they were automatically directed to a WhatsApp business line, and the chatbot began after participants sent an initial message to the line. In response to the first message sent by participants, the chatbot replied with a message briefly describing the game and participants were asked if they wanted to continue. Participants who opted in were then provided additional background information about the study and contact information for the researchers, completing the informed consent protocol. For more information, please find our Working Paper.

A total of 2,851 participants completed the study. Of them, 63% identified as male and 33% as female; 49% reported having completed secondary education (3% with no education, 12% with primary, and 3% with tertiary education); 53% reported being between the ages of 18 and 29, 25% in their 30s, 13% in their 40s, and 5% over the age of 50. Finally, 85% reported being vaccinated for COVID-19, 5% unvaccinated but willing to vaccinate, and 5% unvaccinated and unwilling to vaccinate. None of the treatment arms reported significant differences in demographics and vaccination status compared to the control group. For more information, please find our Working Paper at https://hdl.handle.net/10986/42216.

Mode of data collection

Internet [int]

Research instrument

Judgements of Misinformation Adapted from Roozenbeek et al. (2022), participants were presented with six headlines: three using misinformation tactics and three that did not use common misinformation tactics. When presented with each headline, participants were asked to respond to the question ‘Does this headline use any misinformation techniques?’ on a 4-point scale: Definitely is misinformation, Probably is misinformation, Probably is not misinformation, Definitely is not misinformation. For ease of interpretation, ratings were scored such that higher scores represent stronger belief that a headline was misinformation (Definitely is misinformation = 4 and Definitely is not misinformation = 1). We chose phrasing that highlighted the term misinformation to increase relevance to policymakers and practitioners, but it is worth noting that much prior research on inoculation measures perceptions of misleadingness rather than misinformation classifications per se (e.g., Roozenbeek et al., 2022). In line with prior literature, we compute three scores to assess accuracy in misinformation detection (Basol et al., 2021; Maertens et al., 2021). First, we calculate a measure of discernment, defined as a participant’s average misinformation scores for misleading headlines minus their average score for headlines without misleading content. With this operationalization, discernment scores could range from -3 to +3 where a score of +3 indicates a participant rated all misinformation headlines as ‘Definitely misinformation’ and all non-misinformation headlines as ‘Definitely not misinformation’ for perfect discernment. We also examine the disaggregated discernment score including the average ratings for the three misleading headlines and ratings for the three non-misleading headlines. As higher ratings correspond to judgements that a headline is using misinformation tactics, more accurate scores would be represented by higher scores on the misleading headlines (representing true positives) and lower scores on the non-misleading headlines (representing true negatives).

Sharing Misinformation Adapted from Basol et al. (2021) and Roozenbeek and van der Linden (2020), sharing of misinformation was assessed with two headlines: one that did not use misinformation tactics and a headline that used misinformation tactics. Each participant was randomly assigned to one of two misleading headlines, a headline that used extreme emotion or a headline that used a false expert. Participants were asked to rate their likelihood of sharing each of the headlines on a four-point scale: (1) Very unlikely to share, (2) Unlikely to share, (3) Likely to share, (4) Very likely to share. As with judgements of misinformation, we report three scores for sharing—discernment of sharing, likelihood of sharing misleading headlines, and likelihood of sharing non-misleading headlines. Discernment of sharing was calculated as the sharing score for non-misleading headline minus the sharing score for the misleading headline. Accordingly, participants with high positive discernment of sharing have lower intentions of sharing misinformation, relative to sharing more non-misinformation.

Self-Report Outcomes Complementing the evaluation of the intervention’s impact on detection and sharing of misinformation, we examined differences in attitudes toward the chatbot game.

Confidence Participants were asked to indicate the extent to which they felt more, the same, or less confident in detecting misinformation after completing the game.

Perceived Difficulty Participants were asked to report whether they thought the game was too difficult, the right level of difficulty, or too easy.

Recommending the Game Participants were asked to indicate the extent to which they would recommend the game to others with three possible response categories: yes, maybe, and no.

For more information, please find our Working Paper.

Oman Exports of human or animal blood, antisera and other blood fractions, vaccines, toxins to Jordan was US$273 during 2022, according to the United Nations COMTRADE database on international trade. Oman Exports of human or animal blood, antisera and other blood fractions, vaccines, toxins to Jordan - data, historical chart and statistics - was last updated on July of 2025.

BackgroundThe World Health Organization has recommended the introduction of HPV vaccines into national immunization programme (NIP), but vaccination coverage remains low worldwide. We assessed the coverage and the parental acceptance of female and male HPV vaccination in Brazil after its introduction into the NIP.MethodsWe conducted a random-digit-dial survey of parents in seven major Brazilian cities from July-2015 to October-2016. A knowledge, attitude and practices questionnaire was developed and validated by expert analysis, semantic analysis, and pre-testing.Results826 out of 2,324 (35.5%) eligible parents completed the interview. Parental acceptance of the HPV vaccine for daughters and sons 18 years of age or less was high (92% and 86%, respectively). Parents refusing vaccination were less likely to know that: HPV is sexually transmitted and causes genital warts, HPV vaccination is more beneficial before sexual debut, and HPV vaccine reactions are minor, and they were more likely to believe HPV vaccination can cause severe adverse events. Parents accepting HPV vaccine for daughters but not forsons were more likely to ignore that the vaccine is recommended for boys. Attitudes associated with HPV vaccine acceptance included: general belief in vaccines, trust in the NIP and in the HPV vaccine efficacy. Among girls eligible for HPV vaccination through the NIP, 58.4% had received a two-dose scheme and 71.1% at least one dose. “No vaccination/missed vaccination at school” was the most common reason for missed HPV vaccination in theNIP.ConclusionsOne year after introduction in the NIP, most parents surveyed in Brazil accepted HPV vaccination for their daughters and sons. Low coverage in the NIP seemed to be due to challenges in adolescent vaccine delivery and HPV vaccination barriers at health-care centers, rather than to vaccine refusal.

BackgroundDespite the advantages of vaccination in preventing maternal and fetal problems, there were many concerns in the medical community regarding vaccine safety for pregnant women, and this has put obstetricians in a challenging situation when it comes to advising their pregnant patients on whether to obtain the vaccineAimThis study was performed to define the level of acceptance of COVID-19 vaccination and assess the impact of COVID-19 attitudes and knowledge on vaccine acceptance between pregnant and lactating Syrian women who are seeking prenatal care services at the clinics in Azraq refugee camp in Jordan.MethodA quantitative, cross-sectional study utilizing a non-probability convenience sample. A validated and reliable self-administered questionnaire consisting of four sections was used.ResultsA total of 412 pregnant/lactating women was recruited The acceptance rate of the COVID-19 vaccine among participants was 86.5%. There was a significant positive moderate association between respondents’ attitudes and knowledge around the COVID-19 vaccine and their acceptance of the vaccine (r = .468, p < .001, r = .357, p < .001), respectively.ConclusionTo effectively mitigate the COVID-19 pandemic and achieve collective protection, decision-makers must intensify the efforts in promoting the importance of maternal vaccination, especially in vulnerable communities that suffer the most from pandemic outcomes.

COVID-19 incidence, mortality, and vaccination rates by race, age, and sex, Michigan, June 2021.

Predictors of attitudes toward receiving periodic doses of the COVID-19 vaccine.

BackgroundCOVID-19 hesitancy among women planning to become pregnant, who are pregnant, and who are breast-feeding is still a global phenomenon. Unfortunately, there is a lack of national educational programs that provide those groups of people with the information they need about the vaccine.ObjectiveThis study investigated the effect of the COVID-19 vaccine tele-educational program on vaccine hesitancy and receiving the vaccine among women planning for pregnancy, pregnant and breast-feeding mothers.MethodsThis study implemented a quasi-experimental pre-post design and was conducted in Jordan. It was a two-time study and had two groups of women; 220 women participated in the control group, and 205 women participated in the intervention group (those received the tele-educational program). All participating women answered the demographic characteristics sheet and the Arabic version of Hesitancy About COVID-19 Vaccination Questionnaire twice.ResultsResults showed that after conducting the program the interventional group reported significantly higher vaccination rate and lower mean score of hesitancy than the control group (M = 24.67, SD = 5.11; M = 27.45, SD = 4.92; respectively) t (423) = -4.116, p-value < 0.001. Moreover, before the program, women in the intervention group reported significantly higher levels of hesitancy compared to those in the same group after the program (M = 28.35, SD = 4.91; M = 24.66, SD = 5.11; respectively) t (204) = 17.83, p-value < 0.001.ConclusionsThe study concluded that awareness of pregnant women after being given the tele-education program about COVID-19 vaccination decreased their hesitancy and improved their willingness to participate in the COVID-19 vaccination. Therefore, health workers should focus on providing scientific-based information about the vaccine to reduce the doubts of pregnant women about participating in the COVID-19.

Despite the well-documented life-saving potential of pneumococcal conjugate vaccines (PCV) and global efforts to widen vaccine availability, access to PCV in middle-income countries (MICs) has remained suboptimal due, in part, to vaccine pricing and limited external funding opportunities. To understand gaps and opportunities for improving vaccine equality, this qualitative study engaged leaders from governments, medical institutions, and health agencies who were based in MICs that did not currently have PCV in their national immunization programs to explore their perspectives on decision-making contexts and constraints related to PCV introduction. In-depth interviews with 17 participants from Egypt, Jordan, Sri Lanka, and Thailand in 2023 documented that, despite high immunization coverage and commitment toward equitable health systems, implementing new vaccines such as PCV has remained challenging. Among the six thematic areas that emerged, two were strong enablers to vaccine implementation: 1) the existence of strong primary healthcare systems; and 2) established policy processes for vaccine decision-making. Three themes that emerged have hindered PCV introduction, including; 1) limited information on disease burden and available vaccine products; 2) competing country health priorities; and 3) financing challenges. The interplay of these thematic areas has documented a paradox unique to MICs, further contributing to inequalities in vaccine access. While a subset of MICs recently became eligible for support from Gavi, the Vaccine Alliance for introducing new vaccines, the marketplace has historically lacked tiered vaccine pricing that MICs could sustain for the long term. This is despite the great need with existing inequities and a substantial proportion of the world’s low-income and displaced populations. Finally, participants said barriers may be alleviated with support from global and regional actors providing technical capacity-strengthening, advocacy, and strategic financial support. These findings are informative for strengthening equality in access to vaccines and developing strategies to introduce and sustain life-saving vaccines, including PCV.